Works about ABIRATERONE acetate

Results: 801
    1
    2
    3
    4
    5
    6
    7
    8
    9

    Enzalutamide as a Fourth- or Fifth-Line Treatment Option for Metastatic Castration-Resistant Prostate Cancer.

    Published in:
    Oncology, 2016, v. 91, n. 5, p. 267, doi. 10.1159/000448219
    By:
    • Badrising, Sushil K.;
    • van der Noort, Vincent;
    • Hamberg, Paul;
    • Coenen, Jules L.L.M.;
    • aarts, Maureen J.;
    • van Oort, Inge M.;
    • van den Eertwegh, alfons J.M.;
    • Los, Maartje;
    • van den Berg, H. Pieter;
    • Gelderblom, Hans;
    • Vrijaldenhoven, Suzan;
    • Kerver, Emile D.;
    • van Voorthuizen, Theo;
    • de Jong, Igle J.;
    • Haanen, John B.;
    • Bergman, andries M.
    Publication type:
    Article
    10
    11
    12
    13
    14
    15

    Association of Concomitant Bone Resorption Inhibitors With Overall Survival Among Patients With Metastatic Castration-Resistant Prostate Cancer and Bone Metastases Receiving Abiraterone Acetate With Prednisone as First-Line Therapy.

    Published in:
    JAMA Network Open, 2021, v. 4, n. 7, p. e2116536, doi. 10.1001/jamanetworkopen.2021.16536
    By:
    • Francini, Edoardo;
    • Montagnani, Francesco;
    • Nuzzo, Pier Vitale;
    • Gonzalez-Velez, Miguel;
    • Alimohamed, Nimira S.;
    • Rosellini, Pietro;
    • Moreno-Candilejo, Irene;
    • Cigliola, Antonio;
    • Rubio-Perez, Jaime;
    • Crivelli, Francesca;
    • Shaw, Grace K.;
    • Zhang, Li;
    • Petrioli, Roberto;
    • Bengala, Carmelo;
    • Francini, Guido;
    • Garcia-Foncillas, Jesus;
    • Sweeney, Christopher J.;
    • Higano, Celestia S.;
    • Bryce, Alan H.;
    • Harshman, Lauren C.
    Publication type:
    Article
    16
    17
    18
    19

    PARP Inhibitors as Monotherapy in Daily Practice for Advanced Prostate Cancers.

    Published in:
    Journal of Clinical Medicine, 2022, v. 11, n. 6, p. 1734, doi. 10.3390/jcm11061734
    By:
    • Teyssonneau, Diego;
    • Thiery-Vuillemin, Antoine;
    • Dariane, Charles;
    • Barret, Eric;
    • Beauval, Jean-Baptiste;
    • Brureau, Laurent;
    • Créhange, Gilles;
    • Fiard, Gaëlle;
    • Fromont, Gaëlle;
    • Gauthé, Mathieu;
    • Ruffion, Alain;
    • Renard-Penna, Raphaële;
    • Mathieu, Romain;
    • Sargos, Paul;
    • Rouprêt, Morgan;
    • Ploussard, Guillaume;
    • Roubaud, Guilhem
    Publication type:
    Article
    20

    Overview of the Development and Use of Akt Inhibitors in Prostate Cancer.

    Published in:
    Journal of Clinical Medicine, 2022, v. 11, n. 1, p. 160, doi. 10.3390/jcm11010160
    By:
    • Gasmi, Anis;
    • Roubaud, Guilhem;
    • Dariane, Charles;
    • Barret, Eric;
    • Beauval, Jean-Baptiste;
    • Brureau, Laurent;
    • Créhange, Gilles;
    • Fiard, Gaëlle;
    • Fromont, Gaëlle;
    • Gauthé, Mathieu;
    • Ruffion, Alain;
    • Renard-Penna, Raphaële;
    • Sargos, Paul;
    • Rouprêt, Morgan;
    • Ploussard, Guillaume;
    • Mathieu, Romain
    Publication type:
    Article
    21
    22
    23
    24
    25
    26
    27

    Adherence to Oral Treatments in Older Patients with Advanced Prostate Cancer, the ADHERE Study: A Prospective Trial of the Meet-URO Network.

    Published in:
    Oncologist, 2022, v. 27, n. 12, p. e949, doi. 10.1093/oncolo/oyac147
    By:
    • Rescigno, Pasquale;
    • Maruzzo, Marco;
    • Rebuzzi, Sara Elena;
    • Murianni, Veronica;
    • Cinausero, Marika;
    • Lipari, Helga;
    • Fratino, Lucia;
    • Gamba, Teresa;
    • Giorgi, Ugo De;
    • Caffo, Orazio;
    • Bimbatti, Davide;
    • Dri, Arianna;
    • Mosca, Alessandra;
    • Giunta, Emilio Francesco;
    • Ermacora, Paola;
    • Vignani, Francesca;
    • Msaki, Aichi;
    • Bonifacio, Barbara;
    • Lombardo, Valentina;
    • Conteduca, Vincenza
    Publication type:
    Article
    28
    29

    Multi-institutional Analysis of the Clinical and Genomic Characteristics of Black Patients with Metastatic Hormone-Sensitive Prostate Cancer.

    Published in:
    Oncologist, 2022, v. 27, n. 3, p. 220, doi. 10.1093/oncolo/oyab057
    By:
    • Freeman, Meredith N;
    • Jang, Albert;
    • Zhu, Jason;
    • Sanati, Farhad;
    • Nandagopal, Lakshminarayanan;
    • Ravindranathan, Deepak;
    • Desai, Arpita;
    • Phone, Audrey;
    • Nussenzveig, Roberto;
    • Jaeger, Ellen;
    • Caputo, Sydney A;
    • Koshkin, Vadim S;
    • Swami, Umang;
    • Basu, Arnab;
    • Bilen, Mehmet A;
    • Agarwal, Neeraj;
    • Sartor, Oliver;
    • Burgess, Earle F;
    • Barata, Pedro C
    Publication type:
    Article
    30
    31
    32
    33

    Pantoprazole Affecting Docetaxel Resistance Pathways via Autophagy (PANDORA): Phase II Trial of High Dose Pantoprazole (Autophagy Inhibitor) with Docetaxel in Metastatic Castration‐Resistant Prostate Cancer (mCRPC).

    Published in:
    Oncologist, 2019, v. 24, n. 9, p. 1188, doi. 10.1634/theoncologist.2018-0621
    By:
    • Hansen, Aaron R.;
    • Tannock, Ian F.;
    • Templeton, Arnoud;
    • Chen, Eric;
    • Evans, Andrew;
    • Knox, Jennifer;
    • Prawira, Amy;
    • Sridhar, Srikala S.;
    • Tan, Susie;
    • Vera‐Badillo, Francisco;
    • Wang, Lisa;
    • Wouters, Bradly G.;
    • Joshua, Anthony M.
    Publication type:
    Article
    34
    35
    36

    Radium‐223 Safety, Efficacy, and Concurrent Use with Abiraterone or Enzalutamide: First U.S. Experience from an Expanded Access Program.

    Published in:
    Oncologist, 2018, v. 23, n. 2, p. 193, doi. 10.1634/theoncologist.2017-0413
    By:
    • Sartor, Oliver;
    • Vogelzang, Nicholas J.;
    • Sweeney, Christopher;
    • Fernandez, Daniel C.;
    • Almeida, Fabio;
    • Iagaru, Andrei;
    • Brown Jr., Alan;
    • Smith, Matthew R.;
    • Agrawal, Manish;
    • Dicker, Adam P.;
    • Garcia, Jorge A.;
    • Lutzky, Jose;
    • Wong, Yu‐Ning;
    • Petrenciuc, Oana;
    • Gratt, Jeremy;
    • Shore, Neal D.;
    • Morris, Michael J.;
    • for the U.S. Expanded Access Program Investigators
    Publication type:
    Article
    37
    38
    39
    40
    41

    A Phase I/II Study of the Investigational Drug Alisertib in Combination With Abiraterone and Prednisone for Patients With Metastatic Castration-Resistant Prostate Cancer Progressing on Abiraterone.

    Published in:
    Oncologist, 2016, v. 21, n. 11, p. 1296, doi. 10.1634/theoncologist.2016-0297
    By:
    • Lin, Jianqing;
    • Patel, Sheel A.;
    • Sama, Ashwin R.;
    • Hoffman‐Censits, Jean H.;
    • Kennedy, Brooke;
    • Kilpatrick, Deborah;
    • Ye, Zhong;
    • Yang, Hushan;
    • Mu, Zhaomei;
    • Leiby, Benjamin;
    • Lewis, Nancy;
    • Cristofanilli, Massimo;
    • Kelly, William Kevin
    Publication type:
    Article
    42
    43
    44
    45

    Effectiveness of Deferred Combined Androgen Blockade Therapy Predicts Efficacy in Abiraterone Acetate Treated Metastatic Castration-Resistant Prostate Cancer Patients after Docetaxel.

    Published in:
    Frontiers in Pharmacology, 2017, p. 1, doi. 10.3389/fphar.2017.00836
    By:
    • Jian-Ri Li;
    • Kun-Yuan Chiu;
    • Shian-Shiang Wang;
    • Cheng-Kuang Yang;
    • Chuan-Shu Chen;
    • Hao-Chung Ho;
    • Chi-Feng Hung;
    • Chen-Li Cheng;
    • Chi-Rei Yang;
    • Cheng-Che Chen;
    • Shu-Chi Wang;
    • Chia-Yen Lin;
    • Chao-Hsiang Chang;
    • Chiann-Yi Hsu;
    • Yen-Chuan Ou
    Publication type:
    Article
    46
    47
    48
    49
    50